Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Mitoxantrone: benefits and risks in multiple sclerosis patients.
Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MS.
Multiple sclerosis in 2014: Progress in MS-classification, mechanisms and treatment.
SoCal Symposium on Glial-Neuronal Interactions in Health & Disease
Rituximab (marketed as Rituxan), Information
Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study.
Natalizumab may reduce cognitive changes and brain atrophy rate in relapsing-remitting multiple sclerosis: a prospective, non-randomized pilot study.
National MS Society: Ralph I. Straus Award
Combination therapy in patients with relapsing-remitting multiple sclerosis (MS) CombiRx
Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem Cells.
Barcelona Pediatric MS and Related Disorders Update Meeting
Headache in relapse and remission phases of multiple sclerosis: A case-control study.
Persistency of neutralizing antibodies depends on titer and interferon-beta preparation.
Radiologically isolated syndrome: 5-year risk for an initial clinical event.
Reversible cerebral vasoconstriction syndrome associated with interferon beta-1a use for multiple sclerosis.
Multiple sclerosis: clinical presentation, diagnosis and treatment.
UCSF Seminar: "Neuron-glia interactions regulate CNS node of Ranvier assembly."
Multiple sclerosis: association with HL-A3.
Masitinib in Patients with Progressive or Relapse-Free Secondary Multiple Sclerosis
Protective effects of monomethyl fumarate at the inflamed blood-brain barrier.
Receptos to deliver scientific presentation at Digestive Disease Week 2012 about the therapeutic role of RPC1063 in inflammatory bowel disease
Episode 3 with Drs. Daren Austin and Susan Van Meter on the MIRROR trial of ofatumumab
Mylan's ANDA for Three Times Per Week Generic Copaxone® 40 mg/mL Accepted for Filing by FDA
Delayed-Release Dimethyl Fumarate and Pregnancy: Preclinical Studies and Pregnancy Outcomes from Clinical Trials and Postmarketing Experience.
Chronic Inflammatory Demyelinating Polyneuropathy Following Anti-TNF-α Therapy With Infliximab for Crohn's Disease.

Pages